Piramal Healthcare Buys Rights To Sell Germany’s PlasmaSelect
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - India's Piramal Healthcare said it has bought the global rights to market blood plasma products of Germany-based PlasmaSelect for an undisclosed amount in a deal that excludes the company's manufacturing unit at Marburg, Germany
You may also be interested in...
Analysts Rate Piramal Healthcare Best Play On Innovator CRAMS
MUMBAI - Piramal Healthcare was rated by Citigroup Analysts as India's best play on innovator CRAMS, following its FY09 earnings call July 24
Analysts Rate Piramal Healthcare Best Play On Innovator CRAMS
MUMBAI - Piramal Healthcare was rated by Citigroup Analysts as India's best play on innovator CRAMS, following its FY09 earnings call July 24
PharmAsia News India Pharma Roundup: Lupin, Strides Arcolab, GSK India, Nicholas Piramal, Jubilant
NEW DELHI - India's fifth largest generic drug firm Lupin wants to buy other drug formulation companies in the U.S., Latin America, Southeast Asia and the Middle East this year to expand its presence overseas its chairman said after announcing a sharp, but expected, drop in earnings for the fourth quarter ended March 31